IGM BIOSCIENCES, INC. (IGMS) Social Stream
IGM BIOSCIENCES INC (IGMS) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering IGM BIOSCIENCES INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-09 | 8 | $119 | $82 | $99.25 | $10.11 | 881.7% |
| 2021-12-13 | 8 | $126 | $51 | $86.625 | $10.11 | 756.82% |
| 2021-12-14 | 8 | $126 | $38 | $78.875 | $10.11 | 680.17% |
| 2021-12-16 | 8 | $126 | $38 | $74.125 | $10.11 | 633.18% |
| 2022-02-10 | 8 | $126 | $25 | $72.5 | $10.11 | 617.11% |
| 2022-02-24 | 8 | $90 | $25 | $64.375 | $10.11 | 536.75% |
| 2022-03-30 | 8 | $90 | $25 | $63.625 | $10.11 | 529.33% |
| 2022-03-31 | 8 | $74 | $30 | $56.857 | $10.11 | 462.38% |
| 2022-04-04 | 7 | $74 | $30 | $55.5 | $10.11 | 448.96% |
| 2022-05-12 | 7 | $74 | $30 | $53.875 | $10.11 | 432.89% |
| 2022-05-17 | 7 | $74 | $30 | $53.75 | $10.11 | 431.65% |
| 2022-08-09 | 8 | $74 | $30 | $51.875 | $10.11 | 413.11% |
| 2022-08-23 | 8 | $61 | $30 | $47.25 | $10.11 | 367.36% |
| 2022-09-17 | 9 | $61 | $30 | $45.777 | $10.11 | 352.79% |
| 2022-10-17 | 10 | $61 | $27.001 | $43.5 | $10.11 | 330.27% |
| 2022-11-04 | 10 | $61 | $27.001 | $43.8 | $10.11 | 333.23% |
| 2022-11-08 | 10 | $61 | $22 | $39.6 | $10.11 | 291.69% |
| 2023-03-30 | 10 | $58 | $22 | $39 | $10.11 | 285.76% |
| 2023-03-31 | 10 | $58 | $20 | $37.2 | $10.11 | 267.95% |
| 2023-05-12 | 10 | $50 | $20 | $31.9 | $10.11 | 215.53% |
| 2023-05-15 | 10 | $49 | $20 | $30.8 | $10.11 | 204.65% |
| 2023-05-16 | 10 | $49 | $19 | $30.1 | $10.11 | 197.73% |
| 2023-05-23 | 10 | $49 | $17 | $29.555 | $10.11 | 192.33% |
| 2023-06-23 | 9 | $49 | $17 | $29.555 | $10.11 | 192.33% |
| 2023-08-04 | 9 | $49 | $15 | $26.111 | $10.11 | 158.27% |
| 2023-08-07 | 10 | $49 | $15 | $25.5 | $10.11 | 152.23% |
| 2023-08-08 | 10 | $48 | $15 | $22.636 | $10.11 | 123.9% |
| 2023-09-14 | 10 | $48 | $11 | $22.091 | $10.11 | 118.51% |
| 2023-11-14 | 10 | $48 | $11 | $21.727 | $10.11 | 114.91% |
| 2023-11-16 | 10 | $48 | $8 | $20.272 | $10.11 | 100.51% |
| 2023-12-05 | 10 | $48 | $8 | $19.818 | $10.11 | 96.02% |
| 2023-12-07 | 10 | $48 | $7 | $19.636 | $10.11 | 94.22% |
| 2023-12-14 | 10 | $48 | $7 | $19.636 | $10.11 | 94.22% |
| 2023-12-15 | 10 | $48 | $7 | $18.545 | $10.11 | 83.43% |
The Trend in the Analyst Price Target
Over the past 43 months, IGMS's average price target has gone down $55.16.
IGMS reports an average of 178.6% for its upside potential over the past 49 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-26 | 10 | 58 | 22 | 39.000 | 21.99 | 77.35% |
| 2023-03-30 | 10 | 58 | 22 | 39.000 | 17.02 | 129.14% |
| 2023-05-23 | 9 | 49 | 17 | 29.555 | 12.01 | 146.09% |
| 2023-08-17 | 10 | 48 | 11 | 22.091 | 7.50 | 194.55% |
| 2023-12-07 | 10 | 48 | 7 | 19.636 | 7.00 | 180.51% |
IGMS Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.2 | 4 | 0 | 6 | 0 | 0 | 10 |
The Trend in the Broker Recommendations
IGMS's average broker recommendation rating worsened by 0.5 over the prior 18 months.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- IGMS has a greater upside potential (average analyst target price relative to current price) than 3823.86% of all US stocks.
- In the context of all US stocks, IGM BIOSCIENCES INC's variance in analysts' estimates is lower than -3649.66% of them.
- IGM BIOSCIENCES INC's average analyst price target is greater than 2279.59% of stocks in the mid market cap category.
- To contextualize these metrics, consider that out of stocks in the mid market cap category, IGM BIOSCIENCES INC's number of analysts covering the stock is higher than 2724.37% of them.
Stocks similar to IGM BIOSCIENCES INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are KRTX, STOK, and PTGX.
View All Top Stocks by Price Target
Make investment decisions regarding IGMS using the data that counts. Try POWR Ratings for free.